[go: up one dir, main page]

KR20120054298A - Composition of skin external application containing fermented soybean leaves extract - Google Patents

Composition of skin external application containing fermented soybean leaves extract Download PDF

Info

Publication number
KR20120054298A
KR20120054298A KR1020100115609A KR20100115609A KR20120054298A KR 20120054298 A KR20120054298 A KR 20120054298A KR 1020100115609 A KR1020100115609 A KR 1020100115609A KR 20100115609 A KR20100115609 A KR 20100115609A KR 20120054298 A KR20120054298 A KR 20120054298A
Authority
KR
South Korea
Prior art keywords
ppm
leaf extract
soybean leaf
fermented soybean
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1020100115609A
Other languages
Korean (ko)
Other versions
KR101737940B1 (en
Inventor
심진섭
박준성
김동현
김덕희
김한곤
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Priority to KR1020100115609A priority Critical patent/KR101737940B1/en
Publication of KR20120054298A publication Critical patent/KR20120054298A/en
Application granted granted Critical
Publication of KR101737940B1 publication Critical patent/KR101737940B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 발효 콩잎 추출물을 유효 성분으로 함유하는 피부 외용제 조성물에 관한 것으로, 보다 상세하게는 발효 콩잎 추출물을 유효성분으로 함유함으로써 피부에서 콜라겐 생성을 촉진하며, MMP-1을 억제하고, 동시에 항산화 효과와 DNA 손상 보호 효과를 통한 피부 노화 억제 및 주름 개선 효과를 갖는 피부 외용제 조성물에 관한 것이다.The present invention relates to an external composition for skin containing fermented soybean leaf extract as an active ingredient, and more particularly, by containing fermented soybean leaf extract as an active ingredient, to promote collagen production in the skin, to inhibit MMP-1, and at the same time an antioxidant effect And it relates to an external composition for skin having a skin aging inhibitory effect and wrinkle improvement through the DNA damage protection effect.

Description

발효 콩잎 추출물을 유효성분으로 함유하는 피부 외용제 조성물{Composition of skin external application containing fermented soybean leaves extract}Composition for skin external application containing fermented soybean leaves extract}

본 발명은 발효 콩잎 추출물을 유효 성분으로 함유하는 피부 외용제 조성물에 관한 것으로, 보다 상세하게는 발효 콩잎 추출물을 유효성분으로 함유함으로써 피부에서 콜라겐 생성을 촉진하며, MMP-1을 억제하고, 동시에 항산화 효과와 DNA 손상 보호 효과를 통한 피부 노화 억제 및 주름 개선 효과를 갖는 피부 외용제 조성물에 관한 것이다.
The present invention relates to an external composition for skin containing fermented soybean leaf extract as an active ingredient, and more particularly, by containing fermented soybean leaf extract as an active ingredient, to promote collagen production in the skin, to inhibit MMP-1, and at the same time an antioxidant effect And it relates to an external composition for skin having the effect of inhibiting skin aging and wrinkle improvement through the DNA damage protection effect.

콩잎은 대두(Glycine max (L.) Merr)의 장미목 콩과에 속하는 한해살이 식물의 잎을 의미한다. 콩잎은 콩잎장아찌와 콩잎김치의 형태로 경상도 지역에서 주로 애용되고 있다. 또한 한방에서는 뱀에 물린 상처의 치료나 피가 섞인 오줌이 나오는 임질 등의 치료에 사용한다. 콩잎은 당뇨병의 예방 또는 치료, 통풍 예방, 지연 또는 치료, 및 항동맥경화 등의 약리적인 효과가 있다고 알려져 있으나, 지금까지 발효 콩잎 추출물을 이용하여 세포 재생 피부 외용제 조성물을 개발하기 위한 어떠한 내용도 교시되거나 기재된 바 없다.
The soybean leaves are the leaves of the annual plant belonging to the rosewood legume of Glycine max (L.) Merr. Bean leaves are commonly used in Gyeongsang-do in the form of bean leaf pickles and bean leaf kimchi. In addition, herbal medicine is used to treat snake bites or gonorrhea with bloody urine. Soybean leaves are known to have pharmacological effects such as preventing or treating diabetes, preventing gout, delaying or treating diabetes, and anti-arteriosclerosis. Or is not described.

이에 본 발명자들은 피부에 안전하면서도 세포 증식 및 세포 재생 효과가 우수하고, 제품으로서의 안정성도 우수한 피부 외용제를 제조하기 위하여 연구하던 중, 발효 콩잎 추출물이 세포 증식 및 세포 재생 효과가 매우 우수한 것을 발견하고 본 발명을 완성하게 되었다.Accordingly, the present inventors have been researching to prepare a skin external preparation which is safe for skin and has excellent cell proliferation and cell regeneration effect and excellent stability as a product, and found that fermented soybean leaf extract has very excellent cell proliferation and cell regeneration effect. The invention was completed.

따라서, 본 발명의 목적은 세포 증식 및 세포 재생 효능이 우수한 피부 외용제 조성물을 제공하는 것이다.
Accordingly, it is an object of the present invention to provide an external composition for skin excellent in cell proliferation and cell regeneration efficacy.

상기한 목적을 달성하기 위하여, 본 발명에서는 발효 콩잎 추출물을 유효성분으로 함유하는 피부 외용제 조성물을 제공한다.
In order to achieve the above object, the present invention provides a skin external preparation composition containing a fermented soybean leaf extract as an active ingredient.

본 발명에 의한 피부 외용제 조성물은 발효 콩잎 추출물을 유효성분으로 함유함으로써 항산화 및 항노화 효과가 우수하였다.
The external preparation composition for skin according to the present invention has excellent antioxidant and anti-aging effects by containing fermented soybean leaf extract as an active ingredient.

본 발명은 발효 콩잎 추출물을 유효성분으로 함유하는 피부 외용제 조성물에 관한 것이다. 본 발명에 의한 피부 외용제 조성물은 발효 콩잎 추출물을 조성물 총 중량에 대하여 0.0001?30 중량%로 함유하는 것이 바람직하다. 그 함량이 0.0001 중량% 미만인 경우에는 상기 추출물에 의한 세포 증식 및 세포 재생 효과 등을 얻을 수 없고, 함량이 30 중량%를 초과하는 경우에는 함량 증가에 비해 효과의 증가가 크지 않기 때문에 비효율적이다.The present invention relates to an external composition for skin containing fermented soybean leaf extract as an active ingredient. The external preparation composition for skin according to the present invention preferably contains 0.001 to 30% by weight of the fermented soybean leaf extract based on the total weight of the composition. If the content is less than 0.0001% by weight can not obtain the effect of cell proliferation and cell regeneration by the extract, etc., if the content is more than 30% by weight is inefficient because the increase of the effect is not large compared to the increase in content.

본 발명에서 유효성분으로 사용하는 발효 콩잎 추출물은 콩잎 추출물 내 유효성분의 함량을 높이기 위하여 콩잎 또는 그 추출물을 발효시켜 제조한 것이다.Fermented soybean leaf extract used as an active ingredient in the present invention is prepared by fermenting soybean leaf or its extract in order to increase the content of the active ingredient in soybean leaf extract.

본 발명의 일 실시예에서 상기 발효 콩잎 추출물은 콩잎을 자연발효, 균발효 또는 염장발효시킨 후 여기에 물 또는 에탄올, 또는 이들의 혼합물을 첨가하여 10?90℃에서 4?24시간 동안 추출하여 제조할 수 있다.In one embodiment of the present invention, the fermented soybean leaf extract is prepared by natural fermentation, homogeneous fermentation or salt fermentation, followed by adding water or ethanol, or a mixture thereof for 4 to 24 hours at 10? 90 ° C. can do.

또한 본 발명의 일 실시예에서 상기 발효 콩잎 추출물은 콩잎을 당업계에 잘 알려진 방법으로 물 또는 에탄올, 또는 이들의 혼합물로 10?90℃에서 4?24시간 동안 추출한 다음 이 추출물을 자연발효, 균발효 또는 염장발효시켜 제조할 수 있다.In addition, the fermented soybean leaf extract in one embodiment of the present invention extracts soybean leaf with water or ethanol, or a mixture thereof for 10 to 90 ℃ for 4 to 24 hours by a method well known in the art and then the extract is natural fermentation, bacteria It can be prepared by fermentation or salt fermentation.

본 발명의 일 실시예에서는 상기 콩잎 또는 그 추출물을 옹기 등의 용기에 담아 음지에 두고 자연환경에서 인위적인 조작없이 1일 내지 1년, 바람직하게는 1일 내지 30일간 발효시키는 과정을 거쳐 자연발효시킬 수 있다. In an embodiment of the present invention, the soybean leaves or extracts thereof are put in a container such as Onggi and placed in a shade, and then fermented through a process of fermentation for 1 to 1 year, preferably 1 to 30 days, without artificial manipulation in a natural environment. Can be.

또한 본 발명의 일 실시예에서는 상기 콩잎 또는 그 추출물에 효모균, 버섯균, 유산균, 누룩균 또는 바실러스속균(고초균) 등 당업계에 공지된 유용한 발효 균주를 접종하여 10?60℃에서 18시간 내지 100일 정도 발효시키는 과정을 거쳐 균발효시킬 수 있다. In addition, in one embodiment of the present invention inoculated useful bean strains known in the art such as yeast, mushroom, lactic acid, yeast, or Bacillus genus (battery) to the soybean leaves or extracts thereof for 18 hours to 100 days at 10 ~ 60 ℃ After the degree of fermentation, it can be fermented.

본 발명에서 사용하는 효모균은 사카로마이세스(Saccharomyces sp .), 스키조사카로마이세스(Schizosaccharomyces sp .), 토룰로프시스(Torulopsis sp .), 로도토룰라(Rhodotorula sp .) 또는 칸디다(Candida sp .) 등을 들 수 있으며, 버섯균은 식용으로 가능한 버섯균이라면 어느 것이나 가능하나, 바람직하게는 차가버섯(Inonnotus - obliquus), 동충하초균류(Cordyceps sinensis , Paecilomyces japonica), 송이버섯(Tricholomamatsutake), 상황버섯(Phellinus linteus) 또는 영지버섯(Ganoderma lucidum) 등을 사용할 수 있다. 또한 유산균은 락토바실러스(Lactobacillus sp .), 스트렙토코쿠스(Streptococcus sp .), 류코노스톡(Leuconostoc sp .) 또는 비피도박테리아(Bifidobacteria sp .) 등을 들 수 있으며, 누룩균은 라이조푸스(Rhyzopus), 우사미(Usami) 및 오리재(Oryzae), 아스퍼질러스 오리재(Aspergillus oryzae) 또는 아스퍼질러스 소재(Aspergillus sojae) 등을 들 수 있고, 바실러스속균(고초균)은 바실러스 리체니포르미스(Bacillus licheniformis) F1017, 바실러스 리체니포르미스(Bacillus licheniformis) F1232, 바실러스 리체니포르미스(Bacillus licheniformis) F1267, 바실러스 리체니포르미스(Bacillus licheniformis) F1268, 바실러스 리체니포르미스(Bacillus licheniformis) F1200, 바실러스 푸미루스(Bacillus pumilus) F1337, 바실러스 소노렌시스(Bacillus sonorensis) F1005, 바실러스 서브틸리스(Bacillus subtilis) F1236 또는 바실러스 서브틸리스(Bacillus subtilis) F1279 등을 들 수 있으나, 이에만 한정되는 것은 아니다.Yeast bacteria used in the present invention is Saccharomyces sp . , Ski investigation caromyces ( Schizosaccharomyces sp . ), Torulopsis sp . Rhodotorula sp . ) Or Candida sp . The fungus can be any mushroom that is edible, but preferably Chaga ( Inonnotus - obliquus ), Cordyceps fungus ( Cordyceps) sinensis , Paecilomyces japonica ), matsutake mushroom ( Tricholomamatsutake ), situation mushroom ( Phellinus) linteus ) or Ganoderma lucidum ( Ganoderma) lucidum ) and the like. In addition, Lactobacillus ( Lactobacillus) sp . ), Streptococcus sp . ), Leuconostoc sp . ) Or Bifidobacteria sp . ) And the like, is nurukgyun rayijo crispus (Rhyzopus), Usami (Usami) and duck material (Oryzae), Aspergillus duck material (Aspergillus oryzae ) or Aspergillus sojae ) and the like, Bacillus genus (Bacillus subtilis) Bacillus licheniformis ( Bacillus licheniformis ) F1017, Bacillus licheniformis ( Bacillus licheniformis) F1232, Bacillus piece you miss PORTO (Bacillus licheniformis) F1267, Bacillus piece you miss PORTO (Bacillus licheniformis) F1268, Bacillus piece you miss PORTO (Bacillus licheniformis) F1200, Bacillus pumi Ruth (Bacillus pumilus) F1337, Bacillus Sono alkylene sheath (Bacillus sonorensis ) F1005, Bacillus subtilis subtilis ) F1236 or Bacillus subtilis ) F1279, etc., but is not limited thereto.

본 발명의 일 실시예에서 효모를 사용하여 발효시킬 경우, 콩잎 또는 그 추출물이 함유된 기본 배지에 일정한 농도(약 105 내지 107 cell/mL)로 효모를 접종하여, pH 5.5?6.5, 온도 25?50℃, 통기량 0.05?0.5 VVM의 조건을 유지하면서 배양한 후, 이 발효액을 원심분리하여 고분자 침전물과 효모균제를 제거함으로써 발효 콩잎 추출물을 수득할 수 있다. 배양 시간은 24 내지 120 시간 정도가 바람직하다.When fermentation using yeast in one embodiment of the present invention, inoculated yeast at a constant concentration (about 10 5 to 10 7 cell / mL) in the basal medium containing soybean leaves or its extract, pH 5.5 ~ 6.5, temperature After culturing while maintaining the conditions at 25-50 ° C. and aeration of 0.05-0.5 VVM, the fermented soybean leaf extract can be obtained by centrifuging the fermentation broth to remove the polymer precipitate and yeast. Incubation time is preferably about 24 to 120 hours.

또한, 본 발명의 일 실시예에서 버섯균을 사용하여 발효시킬 경우, 콩잎 또는 그 추출물에 버섯균을 접종하여, 온도 18?25℃, 습도 60?80%의 조건을 유지하면서 배양한 후, 물이나 탄소수 1?4의 무수 또는 함수 저급 알코올(예를 들어, 메탄올, 에탄올, 프로판올 및 부탄올 등), 상기 저급 알코올과 물의 혼합 용매, 아세톤, 에틸아세테이트, 클로로포름, 1,3-부틸렌글리콜, 헥산 또는 디에틸에테르 중 1종 이상을 이용하고, 50?100℃, 1?5시간 동안 가열하여 감압 농축하여 발효 콩잎 추출물을 수득할 수 있다. 배양 시간은 1일 내지 100일 정도가 바람직하다. In addition, in one embodiment of the present invention, when fermented with mushrooms, inoculate mushrooms to soybean leaves or extracts thereof, and then cultured while maintaining the conditions of temperature 18 ~ 25 ℃, humidity 60 ~ 80%, water Or anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms (for example, methanol, ethanol, propanol and butanol), a mixed solvent of the lower alcohol and water, acetone, ethyl acetate, chloroform, 1,3-butylene glycol, hexane Alternatively, by using at least one of diethyl ether, and heated under 50 ~ 100 ℃, 1-5 hours can be concentrated under reduced pressure to obtain a fermented soybean leaf extract. Incubation time is preferably about 1 to 100 days.

또한, 본 발명의 일 실시예에서 유산균을 사용하여 발효시킬 경우, 콩잎 또는 그 추출물이 함유된 기본 배지에 일정한 농도(약 105 내지 107 cell/mL)로 유산균을 접종하여, pH 6.5?7.5, 온도 25?50℃, 통기량 1VVM의 조건을 유지하면서 배양한 후, 이 발효액을 원심분리하여 고분자 침전물과 유산균제가 제거된 발효 콩잎 추출물을 수득할 수 있다. 배양 시간은 24 내지 120 시간 정도가 바람직하다.In addition, when the fermentation using lactic acid bacteria in one embodiment of the present invention, by inoculating the lactic acid bacteria at a constant concentration (about 10 5 to 10 7 cell / mL) in the basal medium containing soybean leaves or its extract, pH 6.5 ~ 7.5 After culturing while maintaining the temperature of 25-50 ° C. and aeration rate of 1 VVM, the fermentation broth extract may be obtained by centrifugation of the fermentation broth to remove the polymer precipitate and the lactic acid bacteria. Incubation time is preferably about 24 to 120 hours.

또한, 본 발명의 일 실시예에서 누룩균을 사용하여 발효시킬 경우, 콩잎 또는 그 추출물에 누룩균을 접종하여, 온도 15?45℃의 조건을 유지하면서 배양한 후, 이 발효액을 원심분리하여 고분자 침전물과 누룩균제가 제거된 발효 콩잎 추출물을 수득할 수 있다. 배양 시간은 18 내지 120 시간 정도가 바람직하다.In addition, when fermentation using Nuruk bacteria in one embodiment of the present invention, inoculated with koji bacteria on soybean leaves or extracts thereof, followed by culturing while maintaining the temperature of 15 ~ 45 ℃, centrifugation of the fermentation broth and polymer precipitates and Fermented soybean leaf extract from which yeast is removed can be obtained. The culture time is preferably about 18 to 120 hours.

또한, 본 발명의 일 실시예에서 바실러스속균을 사용하여 발효시킬 경우, 콩잎 또는 그 추출물이 함유된 기본 배지에 일정한 농도(약 105 내지 107 cell/mL)로 바실러스속균을 접종하여, 온도 10?60℃의 조건을 유지하면서 배양한 후, 이 발효액을 원심분리하여 pH 5.5?8.5, 고분자 침전물과 바실러스균제가 제거된 발효 콩잎 추출물을 수득할 수 있다. 배양 시간은 24 내지 96 시간 정도가 바람직하다.
In addition, when fermented using Bacillus genus in one embodiment of the present invention, Bacillus genus inoculated at a constant concentration (about 10 5 to 10 7 cell / mL) in the basal medium containing soybean leaves or its extract, temperature 10 After culturing while maintaining the condition of -60 ℃, this fermentation broth can be centrifuged to obtain a fermented soybean leaf extract from which pH 5.5-8.5, polymer precipitates and Bacillus bacteria are removed. Incubation time is preferably about 24 to 96 hours.

또한 본 발명의 일 실시예에서는 1) 콩잎 또는 그 추출물에 일정량의 소금을 첨가하여 장기 숙성 발효시키는 단계; 및 2) 상기 염장 발효물을 물 또는 유기용매로 추출하여 발효 추출물을 수득하는 단계;를 거쳐 염장 발효시킬 수 있다.In addition, in one embodiment of the present invention 1) adding a certain amount of salt to the soybean leaves or extracts of the long-term aging fermentation; And 2) extracting the salted fermented product with water or an organic solvent to obtain a fermented extract.

상기 1) 단계에서, 염장에 사용되는 소금으로는 정제한 고순도 염화나트륨, 천일염, 암염 및 죽염 등이 바람직하며, 소금의 농도는 전체 발효물에 대하여 10?30 중량%가 바람직하다. 소금의 함량이 10 중량% 미만에서는 기대하는 효과를 발휘하기가 어렵고, 30 중량%를 초과하면 효과의 변화가 미미하다.In the step 1), the salt used for salting is preferably purified high purity sodium chloride, sun salt, rock salt and bamboo salt, and the concentration of salt is preferably 10 to 30% by weight based on the total fermented product. When the content of salt is less than 10% by weight, it is difficult to achieve the expected effect, and when it exceeds 30% by weight, the effect is not changed.

상기 1)의 발효공정은 4 내지 40℃ 사이에서, 충분한 발효가 일어날 수 있도록 1일에서 1년 정도, 바람직하게는 1일 내지 30일 정도가 발효시키는 것이 좋다. 4℃ 미만에서는 유용 미생물의 성장이 잘 되지 않고 40℃를 초과할 경우 미생물의 성장이 너무 과하게 일어나 콩잎 또는 그 추출물의 성능에 영향을 미칠 수 있다.The fermentation process of 1) is between 4 to 40 ℃, so that enough fermentation can occur from 1 day to 1 year, preferably 1 to 30 days is good to ferment. If it is less than 4 ℃, the growth of useful microorganisms is not well, and if it exceeds 40 ℃ can grow too much microbial may affect the performance of the soybean leaves or its extract.

상기 2) 단계에서 사용하는 추출 용매로는 정제수, 메탄올, 에탄올, 글리세린, 에틸아세테이트, 부틸렌글리콜, 프로필렌글리콜, 디클로로메탄 및 헥산으로 이루어진 그룹에서 선택된 1종을 단독으로 또는 2종 이상 혼합하여 사용할 수 있다. 이때, 추출온도는 10 내지 80℃가 바람직하며, 6시간 내지 24시간 동안 추출할 수 있다. 상기 추출온도 및 추출시간을 벗어나면 추출 효율이 떨어지거나 성분의 변화가 생길 수 있다.The extraction solvent used in step 2) may be used alone or in combination of two or more selected from the group consisting of purified water, methanol, ethanol, glycerin, ethyl acetate, butylene glycol, propylene glycol, dichloromethane and hexane. Can be. At this time, the extraction temperature is preferably 10 to 80 ℃, it can be extracted for 6 hours to 24 hours. If the extraction temperature and extraction time is out of the extraction efficiency may decrease or change of components may occur.

본 발명에서는 상기 2) 단계 이후 당업계에 알려진 통상적인 방법으로 상온에서 냉침, 가열 및 여과하여 얻어진 액상물 또는 추가로 용매를 증발, 분무건조 또는 동결건조하여 콩잎의 염장 발효 추출물의 제조할 수 있다.
In the present invention, the salt or fermented extract of soybean leaves may be prepared by evaporation, spray drying or lyophilization of the liquid obtained by cooling, heating and filtration at room temperature in a conventional method known in the art after step 2). .

본 발명에 의한 발효 콩잎 추출물은 그 사용에 특별히 제한되지 않으며, 예를 들면, 피부 외용제 조성물 이외에도 약제 조성물 등에 사용될 수 있다.Fermented soybean leaf extract according to the present invention is not particularly limited to its use, for example, it can be used in pharmaceutical compositions and the like in addition to the external preparation composition for the skin.

또한 본 발명에 의한 피부 외용제 조성물은 당업계에서 통상적으로 사용하는 화장품학 또는 피부과학적으로 허용가능한 매질 또는 기제를 더 함유할 수 있다. 이는 당해 분야의 통상적인 방법에 따라 국소적용에 적합한 모든 제형으로, 예를 들면, 용액, 겔, 고체, 반죽 무수 생성물, 수상에 유상을 분산시켜 얻은 에멀젼, 현탁액, 마이크로에멀젼, 마이크로캡슐, 미세과립구 또는, 이온형(리포좀) 및 비이온형의 소낭 분산제의 형태로, 또는 크림, 스킨, 로션, 파우더, 연고, 스프레이 또는 콘실 스틱의 형태로 제조될 수 있다. 본 발명에 의한 피부 외용제 조성물은 또한 포말(foam)의 형태로 또는 압축된 추진제를 더 함유한 에어로졸 조성물의 형태로도 제조될 수 있다.In addition, the topical skin composition according to the present invention may further contain a cosmetically or dermatologically acceptable medium or base commonly used in the art. These are all formulations suitable for topical application according to conventional methods in the art, for example emulsions, suspensions, microemulsions, microcapsules, microgranules, obtained by dispersing the oil phase in solutions, gels, solids, pasty anhydrous products, aqueous phases. Alternatively, they may be prepared in the form of ionic (liposomal) and nonionic vesicle dispersants, or in the form of creams, skins, lotions, powders, ointments, sprays, or cone sticks. The external preparation composition for skin according to the present invention may also be prepared in the form of a foam or in the form of an aerosol composition further containing a compressed propellant.

또한 본 발명에 의한 피부 외용제 조성물은 지방 물질, 유기용매, 용해제, 농축제, 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제, 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품학 또는 피부과학 분야에서 통상적으로 사용되는 보조제를 더 함유할 수 있으며, 상기 보조제는 화장품학 또는 피부과학 분야에서 일반적으로 사용되는 양으로 도입될 수 있다.In addition, the composition for external application for skin according to the present invention may be a fatty substance, an organic solvent, a dissolving agent, a thickening agent, a gelling agent, a softening agent, an antioxidant, a suspending agent, a stabilizer, a foaming agent, a fragrance, a surfactant, water, an ionic type or Nonionic emulsifiers, fillers, metal ion sequestrants, chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or any other ingredients commonly used in cosmetics It may further contain an adjuvant commonly used in the cosmetic or dermatological field, such as may be introduced in an amount generally used in the cosmetic or dermatological field.

또한 본 발명에 의한 피부 외용제 조성물은 그 제형에 있어서 특별히 한정되는 바가 없으며, 예를 들면, 유연화장수, 수렴화장수, 영양화장수, 영양크림, 마사지크림, 에센스, 아이크림, 아이에센스, 클렌징 크림, 클렌징 폼, 클렌징 워터, 팩, 파우더, 바디로션, 바디크림, 바디오일 또는 바디에센스 등의 화장료로 제형화될 수 있다.
In addition, the topical skin composition according to the present invention is not particularly limited in the formulation, for example, softening longevity, astringent longevity, nourishing longevity, nutrition cream, massage cream, essence, eye cream, eye essence, cleansing cream, cleansing It may be formulated into a cosmetic such as foam, cleansing water, pack, powder, body lotion, body cream, body oil or body essence.

이하, 본 발명의 내용을 실시예 및 시험예를 통하여 보다 구체적으로 설명한다. 이들 실시예는 본 발명의 내용을 이해하기 위해 제시되는 것일 뿐 본 발명의 권리범위가 이들 실시예 및 시험예로 한정되는 것은 아니고, 당업계에서 통상적으로 주지된 변형, 치환 및 삽입 등을 수행할 수 있으며, 이에 대한 것도 본 발명의 범위에 포함된다.
Hereinafter, the present invention will be described more specifically with reference to examples and test examples. These examples are provided only for understanding the contents of the present invention, but the scope of the present invention is not limited to these examples and test examples, and modifications, substitutions, and insertions commonly known in the art may be performed. It may be included in the scope of the present invention.

[실시예 1] 발효 콩잎 추출물 제조Example 1 Preparation of Fermented Soybean Leaf Extract

콩잎 1.5 kg을 물 2 ℓ에 넣고 중불(60?80℃)에서 1시간 동안 삶았다. 삶은 콩잎을 건져낸 뒤 상온에서 1시간 동안 식혀주고 식은 콩잎을 옹기에 넣어 음지에서 상온조건으로 7일간 보관하였다. 이후 콩잎을 믹서기로 분쇄한 뒤 80% 에탄올 수용액 7 ℓ를 넣고, 3회 환류 추출한 다음, 15℃에서 1일간 침적시켰다. 그 후, 여과포 여과와 원심분리를 통해 잔사와 여액을 분리하고, 분리된 여액을 감압 농축하여 발효 콩잎 추출물 357 g을 얻었다.
1.5 kg of soybean leaves were put in 2 L of water and boiled at medium heat (60-80 ° C) for 1 hour. The boiled bean leaves were taken out and cooled down at room temperature for 1 hour, and the cooled bean leaves were placed in Onggi for 7 days at room temperature. After crushing the soybean leaves with a blender and put 7 L of 80% ethanol aqueous solution, three times reflux extraction, and then was deposited at 15 ℃ for 1 day. Thereafter, the residue and the filtrate were separated through filter cloth filtration and centrifugation. The separated filtrate was concentrated under reduced pressure to obtain 357 g of the fermented soybean leaf extract.

[비교예 1] 콩잎 추출물 제조Comparative Example 1 Preparation of Soybean Leaf Extract

콩잎 1.5 kg을 믹서기로 분쇄한 뒤 80% 에탄올 수용액 7 ℓ를 넣고, 3회 환류 추출한 다음, 15℃에서 1일간 침적시켰다. 그 후, 여과포 여과와 원심분리를 통해 잔사와 여액을 분리하고, 분리된 여액을 감압 농축하여 콩잎 추출물 357 g을 얻었다.
1.5 kg of soybean leaves were pulverized with a blender, 7 L of an 80% ethanol aqueous solution was added thereto, and refluxed three times, followed by immersion at 15 ° C. for 1 day. Thereafter, the residue and the filtrate were separated through filter cloth filtration and centrifugation. The separated filtrate was concentrated under reduced pressure to obtain 357 g of a soybean leaf extract.

[실시예 2] 효모를 이용한 발효 콩잎 추출물Example 2 Fermented Soybean Leaf Extract Using Yeast

상기 비교예 1의 콩잎 추출물을 1.5 ℓ의 정제수에 5중량%가 되도록 첨가하여 탄소원, 질소원, 인산염, 무기염류 및 미량영양성분 등을 기본 조성으로 하고, 수산화나트륨을 이용하여 적절한 pH 5.5?6.5로 맞추었다. 상기 콩잎 추출물이 함유된 배양 배지에 사카로마이세스(Saccharomyces sp .)를 106 cell/mL로 접종하고, pH 5.5?6.5, 온도 25?35℃, 통기량 0.5 VVM의 조건을 유지하면서 72시간 동안 배양하였다.The soybean leaf extract of Comparative Example 1 was added to 1.5 L of purified water so that 5 wt% was used as the basic composition of carbon source, nitrogen source, phosphate, inorganic salts and micronutrient components, and using sodium hydroxide to pH 5.5-6.5 appropriate. Fit. Saccharomyces in the culture medium containing the soybean leaf extract ( Saccharomyces sp . ) Was inoculated at 10 6 cells / mL, and cultured for 72 hours while maintaining the conditions of pH 5.5-6.5, temperature 25-35 ° C, and aeration 0.5 VVM.

상기 발효액을 1.000xg에서 30분간 원심분리하여 고분자 침전물과 효모균체가 제거된 최종 발효 콩잎 추출물을 얻었다.
The fermentation broth was centrifuged at 1.000xg for 30 minutes to obtain a final fermented soybean leaf extract from which polymer precipitates and yeast cells were removed.

[실시예 3] 버섯균을 이용한 발효 콩잎 추출물Example 3 Fermented Soybean Leaf Extract Using Mushroom Bacteria

상기 비교예 1의 콩잎 추출물에 동충하초균류(Paecilomyces japonica)를 5 중량%로 첨가하고, 18?25℃, 습도 60?70%에서 60일간 발효시킨 후 건조시킨 다음, 이를 분쇄하여 얻어진 분쇄물 100 g씩을 80% 메탄올 3 ℓ에 각각 넣고 냉각콘덴서가 달린 환류추출기에서 3시간 끓여 추출하였다. 그 다음 100 메쉬 여과포로 여과한 후 잔사를 같은 방법으로 1회 더 추출하였다. 각각의 추출액을 합하여 상온에서 와트만 2번 여과지로 여과하여 불용성 물질을 제거한 후, 냉각 콘덴서가 달린 증류장치에서 60℃로 감압농축한 후 동결건조하여 최종 발효 콩잎 추출물을 얻었다.
Cordyceps fungi ( Paecilomyces) on the soybean leaf extract of Comparative Example 1 japonica ) was added at 5% by weight, fermented at 18-25 ° C. and humidity 60-70% for 60 days, dried, and then ground. Boiled in reflux extractor for 3 hours and extracted. Then filtered through 100 mesh filter cloth and the residue was extracted once more in the same way. Each extract was combined and filtered with Whatman No. 2 filter paper at room temperature to remove insoluble materials, concentrated under reduced pressure at 60 ° C. in a distillation apparatus equipped with a cooling condenser, and lyophilized to obtain a final fermented soybean leaf extract.

[실시예 4] 유산균을 이용한 발효 콩잎 추출물Example 4 Fermented Soybean Leaf Extract Using Lactic Acid Bacteria

상기 비교예 1의 콩잎 추출물을 1.5 ℓ의 정제수에 5 중량%가 되도록 첨가하여 탄소원, 질소원, 인산염, 무기염류, 미량영양성분 등을 기본 조성으로 하고, 수산화나트륨을 이용하여 적절한 pH 5.5?6.5로 맞추었다. 상기 콩잎 추출물이 함유된 배양 배지에 락토바실러스(Lactobacillus sp .)를 106 cell/mL로 접종하고, pH 6.5?7.5, 온도 35?38℃, 통기량 1 VVM의 조건을 유지하면서 72시간 동안 배양하였다.The soybean leaf extract of Comparative Example 1 was added to 1.5 L of purified water so as to be 5% by weight, and the carbon composition, nitrogen source, phosphate, inorganic salts, and micronutrient components were used as basic compositions, and sodium hydroxide was used at an appropriate pH of 5.5 to 6.5. Fit. Lactobacillus in the culture medium containing the soybean leaf extract sp . ) Was inoculated at 10 6 cells / mL, and cultured for 72 hours while maintaining the conditions of pH 6.5-7.5, temperature 35-38 ° C, and aeration volume 1 VVM.

상기 발효액을 1.000xg에서 30분간 원심분리하여 고분자 침전물과 유산균 균체가 제거된 최종 발효 콩잎 추출물을 얻었다.
The fermentation broth was centrifuged at 1.000xg for 30 minutes to obtain a final fermented soybean leaf extract from which polymer precipitates and lactic acid bacteria cells were removed.

[실시예 5] 누룩균을 이용한 발효 콩잎 추출물Example 5 Fermented Soybean Leaf Extract Using Nuruk

상기 비교예 1의 콩잎 추출물에 아스퍼질러스 오리재(Aspergillus oryzae)를 5중량%로 첨가하고, 25℃에서 48시간 동안 발효시킨 후 건조시킨 다음, 이를 분쇄하여 얻어진 분쇄물 100 g씩을 80% 메탄올 3 ℓ에 각각 넣고 냉각콘덴서가 달린 환류추출기에서 3시간 끓여 추출하였다. 그 다음 100 메쉬 여과포로 여과한 후 잔사를 같은 방법으로 1회 더 추출하였다. 각각의 추출액을 합하여 상온에서 와트만 2번 여과지로 여과하여 불용성 물질을 제거한 후, 냉각 콘덴서가 달린 증류장치에서 60℃로 감압농축한 후 동결건조하여 최종 발효 콩잎 추출물을 얻었다.
5% by weight of Aspergillus oryza ( Aspergillus oryzae ) was added to the soybean leaf extract of Comparative Example 1, fermented at 25 ° C. for 48 hours, dried, and then ground. Each was put in 3 l and extracted by boiling for 3 hours in a reflux extractor with a cooling capacitor. Then filtered through 100 mesh filter cloth and the residue was extracted once more in the same way. Each extract was combined and filtered with Whatman No. 2 filter paper at room temperature to remove insoluble materials, concentrated under reduced pressure at 60 ° C. in a distillation apparatus equipped with a cooling condenser, and lyophilized to obtain a final fermented soybean leaf extract.

[실시예 6] 바실러스균을 이용한 발효 콩잎 추출물Example 6 Fermented Soybean Leaf Extract Using Bacillus

상기 비교예 1의 콩잎 추출물을 1.5 ℓ의 정제수에 5 중량%가 되도록 첨가하여 탄소원, 질소원, 인산염, 무기염류 및 미량영양성분 등을 기본 조성으로 하고, 수산화나트륨을 이용하여 적절한 pH 5.5?6.5로 맞추었다. 상기 콩잎 추출물이 함유된 배양 배지에 바실러스 서브틸리스(Bacillus subtilis) F1279를 접종하고, 45℃에서 72시간 동안 배양하였다.The soybean leaf extract of Comparative Example 1 was added to 1.5 L of purified water so that 5 wt% was used as the basic composition of carbon source, nitrogen source, phosphate, inorganic salts and micronutrient components, and using sodium hydroxide to pH 5.5-6.5 appropriate. Fit. Bacillus subtilis ( Bacillus) in the culture medium containing the soybean leaf extract subtilis ) F1279 was inoculated and incubated at 45 ° C. for 72 hours.

상기 발효액을 1.000xg에서 30분간 원심분리하여 고분자 침전물과 바실러스 균체가 제거된 최종 발효 콩잎 추출물을 얻었다.
The fermentation broth was centrifuged at 1.000xg for 30 minutes to obtain a final fermented soybean leaf extract from which polymer precipitates and Bacillus cells were removed.

[실시예 7] 콩잎 염장 발효 추출물 제조Example 7 Preparation of Soybean Leaf Salted Fermented Extract

콩잎 1 kg을 깨끗한 물로 씻어 건조시킨 후 10 중량% 농도의 소금 용액에 혼합한 다음 옹기에 담아 준비하고 4℃에서 약 30일간 발효시킨 후 여기에 80% 에탄올 수용액 5 ℓ를 넣고, 3회 환류 추출한 다음, 15℃에서 1일간 침적시켰다. 그 후, 여과포 여과와 원심분리를 통해 잔사와 여액을 분리하고, 분리된 여액을 감압농축하여 얻은 추출물을 물에 현탁한 다음, 에테르 1ℓ로 5회 추출하여 색소를 제거하고, 수층을 1-부탄올 500 ㎖로 3회 추출하였다. 이로부터 얻은 총 1-부탄올층을 감압농축하여 1-부탄올 추출물을 얻고, 이를 소량의 메탄올에 녹인 후, 대량의 에틸아세테이트에 추가하여, 생성된 침전물을 건조함으로써, 콩잎의 염장 발효 추출물 50.3 g을 수득하였다.
After washing 1 kg of soybean leaves with clean water and drying it, mix it with a salt solution of 10 wt% concentration, prepare it in Onggi, ferment at about 4 ℃ for 30 days, add 5 L of 80% ethanol aqueous solution, and reflux 3 times. Next, it was immersed at 15 degreeC for 1 day. Thereafter, the residue and the filtrate were separated by filter cloth filtration and centrifugation, and the extract obtained by concentrating the separated filtrate under reduced pressure was suspended in water, extracted five times with 1 L of ether to remove the pigment, and the aqueous layer was 1-butanol. Extracted three times with 500 mL. The total 1-butanol layer thus obtained was concentrated under reduced pressure to obtain a 1-butanol extract, which was dissolved in a small amount of methanol, and then added to a large amount of ethyl acetate, followed by drying the resulting precipitate. Obtained.

[시험예 1] 항산화 효과: DPPH 테스트Test Example 1 Antioxidant Effect: DPPH Test

상기 실시예 1?7 및 비교예 1에서 제조한 추출물의 항산화 효과를 알아보기 위하여, 유기 라디칼인 DPPH(1,1-디페닐-2-피크릴하이드라질; 1,1-diphenyl-2-picryl hydrazyl)의 환원에 의해(항산화제는 산화됨) 발생되는 흡광도의 변화를 통해 DPPH 산화 억제 효능을 비교 측정함으로써 항산화능을 평가하는 방법으로 수행하였다. 즉, 상기 실시예 1?7 및 비교예 1에서 제조한 추출물에 대해 DPPH의 산화가 억제되어 흡광도가 대조군에 비해 감소되는 정도를 측정하여, 대조군의 흡광도에 비해서 50% 이하의 흡광도를 나타내는 농도를 유효 항산화 농도로 평가하였다.In order to examine the antioxidant effects of the extracts prepared in Examples 1-7 and Comparative Example 1, the organic radical DPPH (1,1-diphenyl-2-picrylhydrazyl; 1,1-diphenyl-2-picryl It was performed by evaluating the antioxidant capacity by comparing the DPPH oxidation inhibition effect by the change in absorbance generated by the reduction of hydrazyl) (antioxidant is oxidized). That is, the concentration of the extracts prepared in Examples 1 to 7 and Comparative Example 1 was inhibited by the inhibition of DPPH and the degree of absorbance was reduced compared to the control group, and the concentration exhibiting absorbance of 50% or less than the absorbance of the control group was measured. Evaluated as effective antioxidant concentration.

100 μM(에탄올에 용해) DPPH 용액 190 ㎕와 상기에서 수득한 비교예 1, 실시예 1?7 및 양성대조군을 각각 10 ㎕씩 넣어 반응액을 만들고 37℃에서 30분간 반응시킨 후 540 nm에서 흡광도를 측정하였다. 상기 양성대조군으로는 널리 사용하고 있는 합성 항산화제인 트롤록스(Trolox)를 사용하였다. 각 물질의 DPPH 분석 결과를 하기 표 1에 나타내었으며, IC50은 첨가한 시료에 의해 흡광도가 50% 감소했을 때의 시료 농도를 의미한다.190 μl of 100 μM (dissolved in ethanol) DPPH solution and 10 μl each of Comparative Example 1, Example 1-7 and the positive control group obtained above were added to make a reaction solution, and reacted at 37 ° C. for 30 minutes and then absorbance at 540 nm. Was measured. As the positive control group, Trolox, a synthetic antioxidant widely used, was used. The results of DPPH analysis of the respective substances are shown in Table 1 below, and IC 50 means the sample concentration when the absorbance was reduced by 50% by the added sample.

DPPH 분석 결과DPPH analysis results 시험물질Test substance IC50(ppm)IC 50 (ppm) 트롤록스(Trolox)Trolox 4545 비교예 1Comparative Example 1 6666 실시예 1Example 1 1919 실시예 2Example 2 2626 실시예 3Example 3 3030 실시예 4Example 4 2323 실시예 5Example 5 2020 실시예 6Example 6 2828 실시예 7Example 7 2727

상기 표 1의 결과에서, 실시예 1?7의 발효 콩잎 추출물의 항산화능은 생품 추출물(비교예 1) 보다 월등히 우수할 뿐만 아니라 양성대조군으로 사용한 합성 항산화제인 트롤록스와 비교하여도 그 효과가 월등히 우수한 것을 확인하였다. In the results of Table 1, the antioxidant capacity of the fermented soybean leaf extract of Examples 1 to 7 is not only superior to the raw material extract (Comparative Example 1), but also its effect is excellent even when compared to trolox, a synthetic antioxidant used as a positive control group. It confirmed that it was excellent.

따라서, 본 발명에 따른 발효 콩잎 추출물은 항산화 효과가 뛰어남을 알 수 있었다.
Therefore, the fermented soybean leaf extract according to the present invention was found to have an excellent antioxidant effect.

[시험예 2] 항노화 효과: 콜라게나제 발현 억제Test Example 2 Anti-aging Effect: Inhibition of Collagenase Expression

상기 실시예 1?7 및 비교예 1에서 제조한 추출물의 콜라게나제 생성 억제능을 측정하였다. The collagenase production inhibitory ability of the extracts prepared in Examples 1-7 and Comparative Example 1 was measured.

인간 정상 섬유아세포를 105개의 농도로 12웰 평판배양기에서 배양한 다음 상기 비교예 1 및 실시예 1?7의 추출물을 각각 1, 10 및 50 ppm의 농도로 포함하는 배지로 교체하였다. 양성대조군으로 TGF-β(Human Transforming Growth Factor-β1, Roche Co.)를 10 ng/㎖의 농도로 포함하는 것을 사용하였으며, 비교예 1, 실시예 1?7 및 TGF-β를 모두 함유하지 않은 것을 음성 대조군으로 사용하였다. 배양 3일째 세포를 수확해서(harvest) ELISA 방법으로 생성된 I형 프로콜라겐(type I procollagen)의 양을 정량하였다. 상기 음성 대조군의 프로콜라겐의 양을 0, 양성 대조군의 프로콜라겐의 양을 100으로 설정하고 각 측정값과의 비교치를 산출하였다. 그 결과를 하기 표 2에 나타내었다.Human normal fibroblasts were cultured in a 12 well plate incubator at a concentration of 10 5 and then the extracts of Comparative Examples 1 and 7 were replaced with a medium containing the concentrations of 1, 10 and 50 ppm, respectively. As a positive control, TGF-β (Human Transforming Growth Factor-β1, Roche Co.) was used at a concentration of 10 ng / ml, and Comparative Example 1, Examples 1-7 and TGF-β were not included. As a negative control. Cells were harvested on the third day of culture to quantify the amount of type I procollagen produced by ELISA. The amount of procollagen of the negative control group was set to 0 and the amount of procollagen of the positive control group was set to 100, and the comparison with each measured value was calculated. The results are shown in Table 2 below.

시험물질Test substance Ⅰ형 프로콜라겐 생합성(%)Type I procollagen biosynthesis (%) 음성 대조군Negative control group 00 실시예 1 Example 1 1 ppm1 ppm 33.733.7 10 ppm10 ppm 41.841.8 50 ppm50 ppm 42.542.5 실시예 2Example 2 1 ppm1 ppm 36.836.8 10 ppm10 ppm 45.645.6 50 ppm50 ppm 49.349.3 실시예 3Example 3 1 ppm1 ppm 40.840.8 10 ppm10 ppm 50.550.5 50 ppm50 ppm 54.654.6 실시예 4Example 4 1 ppm1 ppm 43.143.1 10 ppm10 ppm 53.453.4 50 ppm50 ppm 57.657.6 실시예 5Example 5 1 ppm1 ppm 39.139.1 10 ppm10 ppm 48.448.4 50 ppm50 ppm 52.352.3 실시예 6Example 6 1 ppm1 ppm 42.042.0 10 ppm10 ppm 52.152.1 50 ppm50 ppm 56.256.2 실시예 7Example 7 1 ppm1 ppm 41.441.4 10 ppm10 ppm 51.351.3 50 ppm50 ppm 55.455.4 비교예 1Comparative Example 1 1 ppm1 ppm 25.925.9 10 ppm10 ppm 30.930.9 50 ppm50 ppm 35.735.7 TGF-β(10 ng/㎖)TGF-β (10 ng / ml) 100100

상기 표 2의 결과에서, 인간 정상 섬유아세포 단층 배양 시스템(Normal human fibroblast monolayer culture system)에서 실시예 1?7의 발효 콩잎 추출물은 음성 대조군과 비교하여 I형 프로콜라겐 생성을 농도 의존적으로 촉진시켰다. 또한, 본 발명에 따른 실시예 1?7의 발효 콩잎 추출물은 상기 비교예 1의 일반 콩잎 추출물보다 I형 프로콜라겐 생성 효과가 우수하였다.In the results of Table 2, the fermented soybean leaf extracts of Examples 1-7 in the normal human fibroblast monolayer culture system promoted type I procollagen production in a concentration-dependent manner compared to the negative control. In addition, the fermented soybean leaf extract of Examples 1 to 7 according to the present invention was superior to the type I procollagen production effect than the general soybean leaf extract of Comparative Example 1.

따라서, 본 발명의 발효 콩잎 추출물은 콜라겐 생성을 촉진함으로써 인체 피부의 노화에 의해 발생하는 콜라겐의 감소 현상을 완화시켜 우수한 항노화 효과를 제공할 수 있음을 확인하였다.
Therefore, the fermented soybean leaf extract of the present invention was confirmed that by promoting collagen production to alleviate the reduction of collagen caused by aging of the human skin can provide an excellent anti-aging effect.

[시험예 3] 항노화 효과: MMP-1 발현 억제Test Example 3 Anti-aging Effect: Inhibition of MMP-1 Expression

인체 섬유아세포를 105 개의 농도로 12웰 평판배양기에서 배양한 다음 자외선 B를 40 mJ/㎠로 조사한 후, 실시예 1?7 및 비교예 1에서 제조한 추출물을 1 및 10 ppm씩 포함한 배지로 교체하였다. 배양 2일째 세포를 수확해서(harvest) ELISA 방법으로 생성된 MMP-1(matrix metalloproteinase I)의 양을 정량하였다. 그 결과는 시험물질을 포함하지 않는 자외선 대조군을 100으로 하여 측정한 값과의 비교치로 산출하였고, 양성대조군은 레티노익산(Retinoic acid; RA, Sigma. 미국)을 사용하였다.Human fibroblasts were incubated in a 12-well plate incubator at a concentration of 10 5 and then irradiated with ultraviolet B at 40 mJ / cm 2, and then the medium prepared in Examples 1 to 7 and Comparative Example 1 was used in a medium containing 1 and 10 ppm, respectively. Replaced. The cells were harvested on the second day of culture (harvest) to quantify the amount of MMP-1 (matrix metalloproteinase I) produced by ELISA. The result was calculated as a comparison with the value measured by using a UV control group containing no test substance 100, the positive control group was used Retinoic acid (RA, Sigma. USA).

시험물질Test substance MMP-1 발현량MMP-1 expression level 대조군Control group 100100 레티노익산 10 μMRetinoic acid 10 μM 4545 실시예 1Example 1 1 ppm1 ppm 5252 10 ppm10 ppm 4646 실시예 2Example 2 1 ppm1 ppm 5757 10 ppm10 ppm 4747 실시예 3Example 3 1 ppm1 ppm 6262 10 ppm10 ppm 5151 실시예 4Example 4 1 ppm1 ppm 5959 10 ppm10 ppm 4646 실시예 5Example 5 1 ppm1 ppm 6363 10 ppm10 ppm 5050 실시예 6Example 6 1 ppm1 ppm 5959 10 ppm10 ppm 5151 실시예 7Example 7 1 ppm1 ppm 6262 10 ppm10 ppm 4949 비교예 1Comparative Example 1 1 ppm1 ppm 113113 10 ppm10 ppm 8282

상기 표 3의 결과에서, 인간 정상 섬유아세포 단층 배양 시스템에서 본 발명에 의한 실시예 1?7의 발효 콩잎 추출물은 UVB 40 mJ/㎠에 의해서 유도되는 MMP-1의 발현을 유의적으로 억제하였다. 따라서, 본 발명에 의한 실시예 1?7의 발효 콩잎 추출물은 내적 노화 또는 외적 환경요인에 의하여 발생하는 피부조직 분해효소인 MMP-1의 생합성을 저해하여 피부노화를 억제하고 주름 개선에 효과가 있음을 확인하였다.
In the results of Table 3, the fermented soybean leaf extract of Examples 1 to 7 according to the present invention in the human normal fibroblast monolayer culture system significantly inhibited the expression of MMP-1 induced by UVB 40 mJ / cm 2. Therefore, the fermented soybean leaf extract of Examples 1 to 7 according to the present invention inhibits the biosynthesis of skin tissue degrading enzyme MMP-1 generated by internal aging or external environmental factors, thereby inhibiting skin aging and improving wrinkles. It was confirmed.

[시험예 3] 항노화 효과: 단 세포 겔 전기영동(SCGE: Single cell gel electrophoresis, Comet assay)에 의한 DNA 산화적 손상에 대한 억제 활성Test Example 3 Anti-aging Effect: Inhibitory Activity against DNA Oxidative Damage by Single Cell Gel Electrophoresis (SCGE)

사람의 정상 섬유아세포를 24시간 배양한 후 실시예 1?7 및 비교예 1에서 제조한 추출물 및 비타민 E를 각각 농도별로 처리하고, 12시간 후에 양성대조군인 H2O2(최종농도 10-3 M)를 처리한 다음 전기영동법으로 염색한 결과를 형광현미경으로 관찰하였다. 이때 이미지분석기(image analyzer)인 KOMET 3.1(Kinetic Imaging, England)를 사용하여 각 세포에서 DNA 절단 결과로 나타난 테일(tail)의 길이(㎛)를 분석하였으며, 그 결과를 하기 표 4에 나타내었다.After culturing human fibroblasts for 24 hours, the extracts prepared in Examples 1-7 and Comparative Example 1 were treated with respective concentrations, and after 12 hours, the positive control group H 2 O 2 (final concentration 10 −3). M) treatment and staining by electrophoresis were observed by fluorescence microscope. At this time, the length (μm) of the tail (tail) as a result of DNA cleavage in each cell was analyzed using KOMET 3.1 (Kinetic Imaging, England), an image analyzer, and the results are shown in Table 4 below.

DNA 산화적 손상에 대한 억제작용Inhibition of DNA Oxidative Damage 시험물질Test substance 테일 길이(㎛)Tail length (μm) 저해율(%)Inhibition rate (%) H2O2 H 2 O 2 115.6115.6 -- H2O2 + 실시예 1 H 2 O 2 + Example 1 10 ppm10 ppm 71.371.3 38.338.3 50 ppm50 ppm 64.564.5 44.244.2 100 ppm100 ppm 58.558.5 49.449.4 H2O2 + 실시예 2H 2 O 2 + Example 2 10 ppm10 ppm 72.872.8 37.037.0 50 ppm50 ppm 72.072.0 37.737.7 100 ppm100 ppm 45.645.6 60.660.6 H2O2 + 실시예 3H 2 O 2 + Example 3 10 ppm10 ppm 70.670.6 38.938.9 50 ppm50 ppm 61.861.8 46.646.6 100 ppm100 ppm 54.654.6 52.752.7 H2O2 + 실시예 4H 2 O 2 + Example 4 10 ppm10 ppm 76.476.4 33.933.9 50 ppm50 ppm 71.471.4 38.238.2 100 ppm100 ppm 42.942.9 62.962.9 H2O2 + 실시예 5H 2 O 2 + Example 5 10 ppm10 ppm 80.680.6 30.230.2 50 ppm50 ppm 77.777.7 32.832.8 100 ppm100 ppm 51.951.9 55.155.1 H2O2 + 실시예 6H 2 O 2 + Example 6 10 ppm10 ppm 74.774.7 35.335.3 50 ppm50 ppm 73.173.1 36.736.7 100 ppm100 ppm 64.764.7 44.044.0 H2O2 + 실시예 7H 2 O 2 + Example 7 10 ppm10 ppm 72.972.9 36.936.9 50 ppm50 ppm 62.962.9 45.645.6 100 ppm100 ppm 53.553.5 53.753.7 H2O2 + 비교예 1H 2 O 2 + Comparative Example 1 10 ppm10 ppm 105.6105.6 8.68.6 50 ppm50 ppm 103.4103.4 10.510.5 100 ppm100 ppm 89.989.9 22.322.3 H2O2 + 비타민 EH 2 O 2 + Vitamin E 10 ppm10 ppm 70.670.6 38.938.9

상기 표 4의 결과에서, 실시예 1?7의 발효 콩잎 추출물은 유의성 있는 산화적 DNA 손상억제 활성을 나타내었으며, 이로 인해 본 발명에 의한 발효 콩잎 추출물이 히드록실 라디칼(.OH)에 의한 DNA 싱글 스트랜드 브레이크(single strand break)를 억제하는 DNA 산화적 손상억제제로서 작용함을 확인할 수 있었다.
In the results of Table 4, the fermented soybean leaf extract of Examples 1-7 showed significant oxidative DNA damage inhibitory activity, whereby the fermented soybean leaf extract according to the present invention is a DNA single by hydroxyl radical (.OH) It was confirmed that it acts as a DNA oxidative damage inhibitor that inhibits the strand strand break.

Claims (4)

발효 콩잎 추출물을 유효성분으로 함유하는 피부 외용제 조성물.Skin external composition containing fermented soybean leaf extract as an active ingredient. 제 1항에 있어서, 상기 발효 콩잎 추출물은 조성물 총 중량에 대하여 0.0001?30 중량%로 함유됨을 특징으로 하는 피부 외용제 조성물.The composition for external application for skin according to claim 1, wherein the fermented soybean leaf extract is contained in an amount of 0.0001 to 30% by weight based on the total weight of the composition. 제 1항에 있어서, 상기 발효 콩잎 추출물은 콩잎 또는 그 추출물을 자연발효, 균발효 또는 염장발효시켜 제조한 것임을 특징으로 하는 피부 외용제 조성물.According to claim 1, wherein the fermented soybean leaf extract is a composition for external application to the skin, characterized in that it is prepared by natural fermentation, homogeneous fermentation or salt fermentation. 제 3항에 있어서, 상기 콩잎 추출물은 콩잎에 물 또는 에탄올, 또는 이들의 혼합물을 첨가하여 10?90℃에서 4?24시간 동안 추출하여 제조한 것임을 특징으로 하는 피부 외용제 조성물.The composition for external application for skin according to claim 3, wherein the soybean leaf extract is prepared by adding water or ethanol or a mixture thereof to the soybean leaf for 4 to 24 hours at 10 to 90 ° C.
KR1020100115609A 2010-11-19 2010-11-19 Composition of skin external application containing fermented soybean leaves extract Expired - Fee Related KR101737940B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020100115609A KR101737940B1 (en) 2010-11-19 2010-11-19 Composition of skin external application containing fermented soybean leaves extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100115609A KR101737940B1 (en) 2010-11-19 2010-11-19 Composition of skin external application containing fermented soybean leaves extract

Publications (2)

Publication Number Publication Date
KR20120054298A true KR20120054298A (en) 2012-05-30
KR101737940B1 KR101737940B1 (en) 2017-05-22

Family

ID=46270189

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100115609A Expired - Fee Related KR101737940B1 (en) 2010-11-19 2010-11-19 Composition of skin external application containing fermented soybean leaves extract

Country Status (1)

Country Link
KR (1) KR101737940B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015194875A1 (en) * 2014-06-19 2015-12-23 (주)아모레퍼시픽 Composition containing danpung bean leaf extract
KR101854158B1 (en) * 2011-10-24 2018-06-14 (주)아모레퍼시픽 Skin External Composition Containing Extracts of Soybean Flower

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190075263A (en) 2017-12-21 2019-07-01 주식회사 메타스크린 Roasting tea from soybean leaf with high content of isoflavone
CN109549211A (en) * 2018-12-20 2019-04-02 江南大学 The method that fermentation process is carried out to soybean or other oil crops using edible and medical fungi
KR20200083853A (en) 2018-12-31 2020-07-09 주식회사 메타스크린 Method for production of fermented tea with Hoban soybean leaf
KR102239470B1 (en) * 2019-08-07 2021-04-12 옥민 Composition for skin whitening comprising extract of fermented black rice with improved antioxidant activity as effective component

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0513193D0 (en) 2005-06-29 2005-08-03 Quest Int Serv Bv Improvements in skin and hair care

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101854158B1 (en) * 2011-10-24 2018-06-14 (주)아모레퍼시픽 Skin External Composition Containing Extracts of Soybean Flower
WO2015194875A1 (en) * 2014-06-19 2015-12-23 (주)아모레퍼시픽 Composition containing danpung bean leaf extract

Also Published As

Publication number Publication date
KR101737940B1 (en) 2017-05-22

Similar Documents

Publication Publication Date Title
US8545905B2 (en) Whitening cosmetic composition containing green tea extract
EP2313082B1 (en) Cosmetic composition for anti-aging of the skin comprising phaseolus radiatus seed extracts by fermentation and enzyme treatment
CN105647974B (en) A kind of saccharomyces cerevisiae plant fermentation object and its application and skin preparations for extenal use
KR101737940B1 (en) Composition of skin external application containing fermented soybean leaves extract
KR101768026B1 (en) Cosmetic Composition for Improving Skin Wrinkle Comprising the Fermented Extract of Morinda citrifolia as Active Ingredient
KR101902988B1 (en) Cosmetic composition comprising the extract of cacao nibs irradiated with far-infrared ray and steamed
KR20210144725A (en) Anti-aging, antioxidant, anti-inflammatory and whitening agents, and cosmetics
KR20130023534A (en) Cosmetic composition for the skin desquamation comprising the citrus junos extracts
KR20190063549A (en) Cosmetic Composition Comprising Bamboo Fermented Extract
KR101040508B1 (en) Skin anti-aging and moisturizing cosmetic composition comprising mung bean fermentation-enzyme extract
KR20220120948A (en) Cosmetic composition for improving melasma, freckles, whitenings and wrinkle comprising extract of fermented chestnut inner shell, angelica dahurica, portulace oleracea, armeniacae and mori dadicis cortex and preparation method thereof
KR102054100B1 (en) Cosmetic composition containing fermented extract of roots
KR20110122448A (en) Cosmetic composition containing gelatin paste extract as an active ingredient
KR20130001842A (en) Cosmetic composition and makeup method for the skin whitening comprising the styrax obassia extracts
KR101855206B1 (en) Cosmetic Composition Comprising the Fermented Extract of Panax ginseng
KR20190045455A (en) Cosmetic composition comprising Phragmites Communis Ferment Extract
KR101761771B1 (en) Method for fermenting Broussonetia plant or the extract thereof, the fermented extracts thereby and the cosmetic composition containing the same
KR20110121775A (en) Cosmetic composition containing the extract of gold pheasant as an active ingredient
KR101843976B1 (en) Cosmetic composition comprising extract of geminated phaseolus radiatus fermented by aureobasidium pullulans
KR20160087507A (en) cosmetic composition containing Phaseolus Radiatus Seed, Phaseolus Vulgaris (Kidney Bean) Seed and Black Soybean extracts by fermentation and enzyme treatment
KR101167606B1 (en) Cosmetic Composition for the Skin Whitening Comprising the Fermented Extract of Mallotus japonicus
KR20160049790A (en) Cosmetic composition comprising the extract of Ensete lasiocarpum as active ingredient
KR20150139679A (en) Cosmetic compositions of Chinese herb medicines extract ferment for soybean fermented liquor
KR20190037436A (en) Cosmetic composition including fermented water lily extract and method for manufacturing the same
KR20110105243A (en) Cosmetic composition for skin whitening comprising mung bean fermentation-enzyme extract

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R11-asn-PN2301

St.27 status event code: A-3-3-R10-R13-asn-PN2301

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

Fee payment year number: 1

St.27 status event code: A-2-2-U10-U11-oth-PR1002

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

PR1001 Payment of annual fee

Fee payment year number: 4

St.27 status event code: A-4-4-U10-U11-oth-PR1001

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

Fee payment year number: 5

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PR1001 Payment of annual fee

Fee payment year number: 6

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PC1903 Unpaid annual fee

Not in force date: 20230516

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

St.27 status event code: A-4-4-U10-U13-oth-PC1903

PC1903 Unpaid annual fee

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20230516

St.27 status event code: N-4-6-H10-H13-oth-PC1903

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

St.27 status event code: A-5-5-R10-R13-asn-PN2301